Did the COVID-19 vaccine result in a net negative outcome across the pandemic? We delve into the key points discussed in the interview conducted by Stephen Bartlett with Dr. Asim Malhotra on "The Diary of a CEO." The conversation touches on the complex and often contentious topic of vaccine efficacy and safety, particularly in relation to heart disease and overall mortality.
Emphasizing the principle of evaluating medical interventions based on all-cause mortality, not just their efficacy against a specific disease. This draws a parallel with aspirin, which, despite its benefits, is not universally prescribed due to potential complications like stomach bleeding. This principle is crucial when considering the widespread administration of COVID-19 vaccines, especially among populations at low risk of severe outcomes from the virus.
Dr. Malhotra, a cardiologist, raises concerns about the association between COVID-19 vaccines and heart disease. He highlights the importance of quality of life for heart disease patients, who often suffer from severe limitations due to their condition. The interview sheds light on the potential increase in heart disease following vaccination, pointing to cases of inflammation and other cardiovascular issues.
One of the most significant points discussed is the potential for COVID-19 vaccines to cause inflammation in the heart. Dr. Malhotra shares anecdotal evidence from a prestigious institution where researchers found inflammation in the arteries of vaccinated individuals but not in the unvaccinated. This finding was not pursued further due to concerns about funding from the pharmaceutical industry. The reluctance to investigate such critical data highlights a troubling conflict of interest within medical research.
References to a critical paper on excess mortality in England post-pandemic, which showed a 7.2% increase in deaths in 2022 compared to a five-year average before the pandemic. This excess mortality persisted into 2023, with significant increases in deaths from cardiovascular diseases. These findings were published in The Lancet but received limited attention, raising questions about the prioritization of vaccine-related data.
Pearson-Stuttard, Jonathan, et al. "Excess mortality in England post COVID-19 pandemic: implications for secondary prevention." The Lancet Regional Health–Europe 36 (2024).
We also touched on the long-term risks associated with COVID-19 vaccines, particularly in relation to autoimmune diseases. I am concerned that stimulating the immune system through vaccination could lead to an overreactive response, potentially exacerbating autoimmune conditions. A study from Italy found a 28% absolute risk of developing autoantibodies post-vaccination, suggesting a significant public health challenge ahead.
The interview with Dr. Malhotra underscores the need for comprehensive and unbiased research into the long-term effects of COVID-19 vaccines. The potential risks, particularly regarding heart disease and autoimmune responses, necessitate a cautious and thorough approach to public health policy. As the medical community navigates these complex issues, it is essential to prioritize patient safety and transparent communication.
We need to encourage further research and innovation to address the challenges posed by the pandemic and its aftermath. There needs to be a revolution in healthcare, so stay informed and engaged through reliable sources and community initiatives. By fostering a collaborative approach, we can better understand and mitigate the long-term impacts of COVID-19 and its vaccines.
Please support my research efforts by subscribing to Vejon Health Substack. Your support allows me to continue bringing you my insights in a timely and effective way.
Covid Vax: More HARM Than Good?